Herbal drug formulation and evaluation

Herbal Drug Formulation and Evaluation, Prof. Dr. Basavaraj K. Nanjwade, KLE University College of Pharmacy, Belagavi.

1. Herbal Drug Formulation and Evaluation
Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D
Department of Pharmaceutics
KLE University College of Pharmacy,
Belgaum-590010
E-mail: [email protected]
Cell No: 0091 9742431000

2. Herbal Drug Formulations
“Herbal formulation shall mean a dosage form
consisting of one or more herbs or processed
herb(s) in specified quantities to provide
specific nutritional, cosmetic benefits, and/or
other benefits meant for use to diagnose treat,
mitigate diseases of human beings or animals
and/or to alter the structure or physiology of
human beings or animals”.
24/08/2011 KLE University College of Pharmacy 2

3. Herbal Medicinal Products
24/08/2011 KLE University College of Pharmacy 3
•Any medicinal product, exclusively containing
as active substances one or more herbal
substances or one or more herbal preparations,
or one or more such herbal substances in
combination with one or more such herbal
preparations

4. Herbal Preparations
•Herbal preparations are obtained by subjecting
herbal substances to treatments such as
extraction, distillation, expression,
fractionation, purification, concentration or
fermentation.
•These include comminuted or powdered herbal
substances, tinctures, extracts, essential oils,
expressed juices and processed exudates.
24/08/2011 KLE University College of Pharmacy 4

5. Herbal Substances
•All mainly whole, fragmented or cut plants, plants
parts, algae, fungi, lichen in an unprocessed, usually
dried form but sometimes fresh.
•Herbal substances are precisely defined by the plant
part used and the botanical name according to the
binomial system (genus, species, variety and author)
24/08/2011 KLE University College of Pharmacy 5

6. Markers
•Markers are chemically defined constituents or
groups of constituents of a herbal substance, a herbal
preparation or a herbal medicinal product which are
of interest for control purpose independent of whether
they have any therapeutic activity.
•Markers serve to calculate the quantity of herbal
substance(s) or herbal preparation(s) in the Herbal
Medicinal Product if the markers has been
quantitatively determined in the herbal substance or
herbal preparations.
24/08/2011 KLE University College of Pharmacy 6

7. Types of Markers
1.Active marker:
2.Analytical marker:
Active marker are constituents or group of
constituents which are generally accepted to
contribute to the therapeutic activity.
Analytical marker are constituents or groups of
constituents that serve for analytical purpose
24/08/2011 KLE University College of Pharmacy 7

8. Characterization of Herbal Drug
1.Characterization
2.Design and development consideration
3.Pharmacopoeial tests and acceptance criteria
4.Periodic/skip testing
5.Release versus shelf-life acceptance criteria
6.In-process tests
7.Alternative procedures
8.Evolving technologies
9.Reference standard
10. Statistical concepts
24/08/2011 KLE University College of Pharmacy 8

9. 24/08/2011 KLE University College of Pharmacy 9

10. Hard gelatin Capsules and
tablets(Coated & uncoated)
a)Dissolution/Disintegration
b)Hardness and friability
c)Uniformity of content and mass (dosage
units)
d)Water content
e)Microbial limits
24/08/2011 KLE University College of Pharmacy 10

11. Oral Liquids
a)Uniformity of content and mass
b)pH
c)Microbial limits
d)Antimicrobial preservative content
e)Antioxidant preservative content
f)Extractable from container/closure system
g)Alcohol content
24/08/2011 KLE University College of Pharmacy 11

12. Oral Liquids
h) Dissolution for suspensions and powders for
suspension
i) Particle size distribution
j) Re-dispensability for suspensions
k) Viscosity for suspensions or viscous solutions
l) Specific gravity for suspensions or viscous
solutions
m) Water content for powders for
reconstitution
24/08/2011 KLE University College of Pharmacy 12

13. Liposomes
–Spherical vesicles with a phospholipid bilayer
Hydrophilic
Hydrophobic
24/08/2011 KLE University College of Pharmacy 13

14. Definition of Liposome
They are simply vesicles or ‘bags’ in which an aqueous
volume is entirely enclosed by a membrane composed of
lipid (fat) molecules, usually phospholipids
24/08/2011 KLE University College of Pharmacy 14

15. Why the Liposomes?
24/08/2011 KLE University College of Pharmacy 15
Liposomes have the advantage of primarily consisting
of lecithin and cholesterol, which are materials that are
occur naturally in the human body. Lecithin and
cholesterol are also present in the body in large amounts
and thus demand good bioacceptability”.

16. Methods of liposomes
preparations
Passive loading
technique
Active loading
technique
Mechanical dispersion
methods
Solvent dispersion
methods
Detergent removal
methods
24/08/2011 KLE University College of Pharmacy 16

17. Liposome Preparation
24/08/2011 KLE University College of Pharmacy 17

18. Liposome Preparation
24/08/2011 KLE University College of Pharmacy 18

19. Liposome Preparation
24/08/2011 KLE University College of Pharmacy 19

20. Physical Characterization
Surface charge Free-flow electrophoresis
Electrical surface potential and
surface pH
Zetapotential measurements & pH sensitive
probes
Percent of free drug/
percent capture
Drug release
Diffusion cell/ dialysis
Parameter Characterization method
Vesicle shape and surface
morphology
Mean vesicle size and size
distribution
Dynamic light scattering, zetasizer,
Photon correlation spectroscopy, laser
light scattering, gel permeation and gel
exclusion
Minicolumn centrifugation, ion-exchange
chromatography, radiolabelling
Transmission electron microscopy,
Freeze-fracture electron microscopy
24/08/2011 KLE University College of Pharmacy 20

21. Phopholipid peroxidation UV absorbance, Iodometric and GLC
Phospholipid hydrolysis,
Cholesterol auto-oxidation
HPLC and TLC
Osmolarity
Parameter
Characterization method
Phospholipid concentration
Cholesterol concentration
Cholesterol oxidase assay and HPLC
Osmometer
Barlett assay, stewart assay, HPLC
Chemical Characterization
24/08/2011 KLE University College of Pharmacy 21

22. Biological Characterization
Animal toxicity Monitoring survival rates, histology and
pathology
Parameter Characterization method
Sterility
Pyrogenicity
Limulus Amebocyte Lysate (LAL) test
Aerobic or anaerobic cultures
24/08/2011 KLE University College of Pharmacy 22

23. Stability
Physical stability :
Once liposomes are formed, they behave similar to the
other colloidal particles suspended in water.
Neutral particles tend to aggregate or flocculate and
sediment with increase in size on storage. Adding
charged lipids such as stearyl amine, diactyl phosphate
and phosphatidyl serine can control the aggregation
The addition of charged lipids causes repulsion and
prevents major changes in the overall size of liposomes.
24/08/2011 KLE University College of Pharmacy 23

24. Chemical stability :
Phospholipids, especially those derived from natural
sources, are subject to two major degradative reaction :
A.Lipid Peroxidation :
Most phospholipid liposomes contain unsaturated acyl
chains as part of their molecular structure and
susceptible to oxidative degradation. It can be
minimized by the use of animal derived lipids like egg
PC, which has less saturated lipids, use of light
resistant containers, use of antioxidants are useful in
minimizing oxidation.
Stability
24/08/2011 KLE University College of Pharmacy 24

25. B. Lipid hydrolysis :
Hydrolysis in phospholipids results in the
formation of free fatty acids and lyso-lecithin.
Selecting a good source of lipid, temperature,
pH, can minimizing oxidation.
Stability
Chemical stability :
24/08/2011 KLE University College of Pharmacy 25

26. Biological stability :
Liposomes release entrapped molecules
rapidly when incubated with blood or plasma.
This instability is attributed to the transfer of
bilayer lipids to albumin and high density
liposomes.
Stability
24/08/2011 KLE University College of Pharmacy 26

27. Modes of Liposome/Cell
Interaction
Adsorption
Endocytosis
Fusion
Lipid transfer
24/08/2011 KLE University College of Pharmacy 27

28. Classes of Liposomes
Conventional Long circulating
Immuno
Cationic
24/08/2011 KLE University College of Pharmacy 28

29. General Case
24/08/2011 KLE University College of Pharmacy 29

30. Proposed criteria and Long-term
testing conditions
24/08/2011 KLE University College of Pharmacy 30

31. Active pharmaceutical ingredient
1.General
2.Stress testing
3.Selection of batches
4.Container closure system
5.Specification
6.Testing frequency
7.Storage conditions
8.Stability commitment
9.Evaluation
10.Statements and labelling
11.Ongoing stability studies
24/08/2011 KLE University College of Pharmacy 31

32. Active Pharmaceutical Ingredients
intended for storage in refrigerator
24/08/2011 KLE University College of Pharmacy 32

33. Active Pharmaceutical Ingredients
intended for storage in a freezer
24/08/2011 KLE University College of Pharmacy 33

34. Finished Pharmaceutical Products
1.General
2.Selection of batches
3.Container closure system
4.Specification
5.Testing frequency
6.Storage conditions
7.Stability commitment
8.Evaluation
9.Statements and labelling
10. In-use stability
11.Variations
12.Ongoing stability studies
24/08/2011 KLE University College of Pharmacy 34

35. General Case
24/08/2011 KLE University College of Pharmacy 35

36. FPPs packaged in semi-permeable
container
24/08/2011 KLE University College of Pharmacy 36

37. Example of an approach for
determining water loss
24/08/2011 KLE University College of Pharmacy 37

38. FPPs intended for storage in a
refrigerator
24/08/2011 KLE University College of Pharmacy 38

39. FPPs intended for storage in a
freezer
24/08/2011 KLE University College of Pharmacy 39

40. Active pharmaceutical ingredients
24/08/2011 KLE University College of Pharmacy 40

41. Finished pharmaceutical products
24/08/2011 KLE University College of Pharmacy 41

42. Finished pharmaceutical products
24/08/2011 KLE University College of Pharmacy 42

43. 24/08/2011 KLE University College of Pharmacy 43

44. Labelling Requirements
1. Proprietary/trade name
2. Local names
3. Dosage form of the product
4. Quantitative list of active ingredients
5. Name and address of manufacturer
6. In case of contract manufacturer
7. Distribution category
8. Precautions
24/08/2011 KLE University College of Pharmacy 44

45. Labelling Requirements
9. Indications and recommended dosage of the
pharmaceutical product
10. In case of products for injection
11. The batch or lot number of the product
12. The manufacturing and expiry date of the
product
13. The name and concentration (content)
14. Storage instruction and shelf-life and the
instruction “keep out of the reach of children”
24/08/2011 KLE University College of Pharmacy 45

46. Packaging Requirements
1. Name and dosage form of the product
2. Identification (description of the product and
package)
3. Quantitative list of active ingredients in a dosage
unit or suitable mass or volume or unit of the
product
4. Indications
5. Dosage regimen and directions for use
6. Contraindications
24/08/2011 KLE University College of Pharmacy 46

47. Packaging Requirements
7. Side effects and adverse reactions
8. Drug interactions
9. Precautions and warnings
10. Symptoms and treatment of overdose
11. Presentation (packing and packing size)
12. Storage instructions and shelf-life
13. Name and address of manufacture and country
of origin
14. Date of publication of the insert.
24/08/2011 KLE University College of Pharmacy 47

48. THANKING YOU
Cell No: 00919742431000
E-mail: [email protected]
24/08/2011 KLE University College of Pharmacy 48